Mumbai: India has revoked a patent granted to GlaxoSmithKline for breast cancer drug Tykerb, a decision that follows a landmark India court ruling disallowing patents for incremental innovations that

India is planning to rein in prices of expensive patented drugs to make medicines affordable to its predominantly poor population, a top government official said on Friday.

GlaxoSmithKline was socked with $3 billion in fines by US authorities on Monday over charges it marketed drugs for unauthorized uses, held back safety data, and cheated the government's Medicaid progr

Leading pharma companies including GlaxoSmithkline, Pfizer and Ranbaxy sell commonly used drugs at a rate 10 times the cost of production, a study by the Corporate Affairs Ministry has found.

A st

Infosys Ltd, India's second-largest software services provider, and Britain's Fabric Worldwide Ltd, a provider of digital marketing technology, won a 'large' order from GlaxoSmithKline PLC to support